eWellness Healthcare Corporation’s (OTC.PK EWLL)( “EWLL”, “the Company”) wholly owned subsidiary has completed its merger with American Health Protection

Rhea-AI Summary

The merger between American Health Protection and EWLL signifies a strategic move to become a leading supplier of Hypochlorous Acid, a popular disinfectant. The company aims to leverage Tritanium Labs' low-cost production capability, forecasting the disinfectant market to reach $1.5 billion by 2027. The merger will allow EWLL to change its name to American Health Protection Corp. and enhance its market position with a nationwide franchising operation. The company expects to be fully compliant with reporting obligations by August 2021, positioning it for significant growth in the post-pandemic environment.

Positive

• Merger facilitates access to low-cost production of Hypochlorous Acid.
• Forecasted market for disinfectants is projected to grow to $1.5 billion by 2027.
• Plans to establish a nationwide franchising operation to enhance distribution.

Negative

• Corporate actions depend on FINRA approval, which may take until mid-late fall 2021.
• Current reporting obligations are not fully met, which could delay corporate actions.

Merger creates one of the lowest cost Domestic Suppliers of Hypochlorous Acid. Demand for surface disinfectants forecasted to significantly increase to $1.5 billion/year by 2027*

Ft. Lauderdale, Florida, June 17, 2021 (GLOBE NEWSWIRE) -- American Health Protection, Inc., a private company (AMHP), has completed its merger with a wholly owned subsidiary of EWLL (OTC.PK: EWLL). EWLL will be filing the signed articles of merger with the appropriate state authorities in the next days. Subsequent to those filings, the Company will file the completed corporate action application with FINRA for its approval of EWLL’s name change to American Health Protection Corp. and other announced corporate actions in the Company’s DEF 14C filed with the SEC on April 19, 2021. EWLL anticipates it may take until mid-late fall for these corporate actions to be approved by FINRA, which approval requires the Company to be current in its reporting obligations under the Exchange Act. The Company has made significant progress in becoming current with a goal of being completely current in or about August 2021.

AMHP, through its Administrative and Finance Agreement with Tritanium Labs USA, LLC, a private company, should benefit from Tritanium’s right to the equipment that produces Hypochlorous Acid (HOCL) at potentially the lowest available cost of production, producing HOCI for cents/gallon. HOCL is a natural disinfectant that can eliminate bacteria and viruses while preserving the environment. The product’s average selling price is typically over $10/gallon. The Company’s plan is to set up a nationwide franchising operation to supplement Tritanium’s existing distribution network through Costco among other US major retailers. David Markowski, CFO of EWLL, stated: “We believe HOCL should be an ideal product as the US emerges from the Covid-19 Pandemic. We believe our relationship with Tritanium should enable us to be a low-cost supplier of the “best in class”, environmentally friendly disinfectant. We believe we should be well positioned to benefit from the recently passed Pandemic Relief Bill that allocates substantial monies for domestic PPE producers such as Tritanium. Even as the country unmasks, we continue to believe disinfectant and sanitizer use will continue to surge and expect that AHMP will become a significant factor in the market.

*According to a recent Fortune Business Insights Article dated 12/8/20 the market for surface disinfectants will reach $1.5 billion in 2027, compared to $770 million in 2019. The Company believes increased disinfectant use represents permanent change as the Pandemic lessens. The Company‘s access to what it believes will be the lowest cost production of this environmentally friendly product, HOCL, should position AMHP, as a wholly owned subsidiary of EWLL, for rapid growth.

Safe Harbor Statement

This news release includes certain information that may constitute forward-looking statements. Forward-looking statements are typically identified by terminology such as “could”, “may,” “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates”, “proposed,” planned, “potential” and similar expressions, or are those, which, by their nature refer to future events. All statements, other than statements of historical fact, included therein including statements about eWellness’ beliefs and expectations, are forward-looking statements. Forward-looking information is necessary based upon a number of assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Although eWellness believes that such statements are reasonable, it can give no assurance that such forward-looking information will prove to be forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors. Accordingly, due to the risks, uncertainties and assumptions inherent in forward-looking information, readers and prospective investors in the Company’s securities should not place undue reliance on forward-looking. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estates of management and information available to management as at the date hereof and is subject to change. The Company assumes no obligation to revise or update forward-looking information to reflect new circumstances, whether as a result of new information, future events or otherwise, except as required by law.

Douglas C. MacLellan
Chairman
eWellness Healthcare Corporation
Email: dmaclellan@mac.com

FAQ

What is the significance of the merger between American Health Protection and EWLL?

The merger aims to create a leading supplier of Hypochlorous Acid, leveraging low-cost production capabilities.

What is the projected market growth for disinfectants by 2027?

The market for surface disinfectants is expected to reach $1.5 billion by 2027.

When will EWLL change its name to American Health Protection Corp.?

The name change is pending FINRA approval, anticipated by mid-late fall 2021.

How does Tritanium Labs contribute to AMHP's business strategy?

Tritanium Labs provides the equipment for low-cost production of Hypochlorous Acid, positioning AMHP for competitive pricing.

What are the potential challenges following the merger?

Delays in FINRA approval and the need to meet current reporting obligations may impact the merger's execution.